Response: Re: Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW

References

1. 1.↵
   1. Lindner SR,
   2. Balasubramanian B,
   3. Marino M,
   4. et al

   . Estimating the cardiovascular disease risk reduction of a quality improvement initiative in primary care: findings from EvidenceNOW. J Am Board Fam Med 2023;36:462–76.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Young RA

   . Re: Estimating the cardiovascular disease risk reduction of a quality improvement initiative in primary care: findings from EvidenceNOW [letter to the editor]. J Am Board FamMed 2023;36:xxx.

   OpenUrl
3. 3.↵
   1. Sanders GD,
   2. Neumann PJ,
   3. Basu A,
   4. et al

   . Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA 2016;316:1093–103.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Franco OH,
   2. Der Kinderen AJ,
   3. De Laet C,
   4. Peeters A,
   5. Bonneux L

   . Primary prevention of cardiovascular disease: cost-effectiveness comparison. Int J Technol Assess Health Care 2007;23:71–9.

   OpenUrlPubMed
5. 5.↵
   1. Mitchell AP,
   2. Simpson RJ

   . Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States. BMC Res Notes 2012;5:1–6.

   OpenUrlCrossRefPubMed
6. 6.
   1. Moran AE,
   2. Odden MC,
   3. Thanataveerat A,
   4. et al

   . Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med 2015;372:447–455.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Gaspoz JM,
   2. Coxson PG,
   3. Goldman PA,
   4. et al

   . Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 2002;346:1800–1806.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Papanicolas I,
   2. Woskie LR,
   3. Jha AK

   . Health care spending in the United States and other high-income countries. JAMA 2018;319:1024–1039.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Anderson GF,
   2. Reinhardt UE,
   3. Hussey PS,
   4. Petrosyan V

   . It’s the prices, stupid: why the United States is so different from other countries. Health Affairs 2003 May;22:89–105.

   OpenUrlAbstract/FREE Full Text